Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection

Bioorganic & Medicinal Chemistry Letters
2013.0

Abstract

The G-protein coupled receptor CXCR4 is a co-receptor for HIV-1 infection and is involved in signaling cell migration and proliferation. In a previous study of non-peptide, guanide-based CXCR4-binding compounds, spermine and spermidine phenylguanides inhibited HIV-1 entry at low micromolar concentrations. Subsequently, crystal structures of CXCR4 were used to dock a series of naphthylguanide derivatives of the polyamines spermidine and spermine. Synthesis and evaluation of the naphthylguanide compounds identified our best compound, spermine tris-1-naphthylguanide, which bound CXCR4 with an IC(50) of 40 nM and inhibited the infection of TZM-bl cells with X4, but not R5, strains of HIV-1 with an IC(50) of 50-100 nM.

Knowledge Graph

Similar Paper

Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection
Bioorganic & Medicinal Chemistry Letters 2013.0
New Bicyclam−AZT Conjugates:  Design, Synthesis, Anti-HIV Evaluation, and Their Interaction with CXCR-4 Coreceptor
Journal of Medicinal Chemistry 1999.0
Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140
Bioorganic & Medicinal Chemistry Letters 2001.0
New bicyclam–GalCer analogue conjugates: synthesis and in vitro anti-HIV activity
Bioorganic & Medicinal Chemistry Letters 2004.0
CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist
Bioorganic & Medicinal Chemistry Letters 2010.0
Isolation and Structure of Antagonists of Chemokine Receptor (CCR5)
Journal of Natural Products 2004.0
The Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100
Antimicrobial Agents and Chemotherapy 2009.0
Pharmacophore-based small molecule CXCR4 ligands
Bioorganic & Medicinal Chemistry Letters 2012.0
Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase
ACS Medicinal Chemistry Letters 2015.0
Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes
Bioorganic & Medicinal Chemistry Letters 2000.0